COPH researchers help identify mutant gene that alters effectiveness of anti-malarial drug regimen
Artemisinin combination therapies (ACTs) have greatly decreased deaths caused by Plasmodium falciparum malaria, a mosquito-borne disease that accounts for roughly 90 percent of the world’s malaria mortality. But Plasmodium falciparum is becoming increasingly resistant to ACTs, making an already dangerous parasite even more threatening. “Like antibiotic drugs used to treat other microbial infections, […]